Literature DB >> 11204091

Sympathetic activation enhances QT prolongation by quinidine.

D Darbar1, M F Fromm, S Dellorto, D M Roden.   

Abstract

INTRODUCTION: Salt restriction results in endogenous sympathetic activation, and we previously showed that plasma concentrations of quinidine measured after oral drug administration are increased during a low-salt diet. However, it is not known whether, independent of effects on plasma concentration, the extent to which quinidine prolongs the QT interval also is modulated by changes in endogenous sympathetic activity. METHODS AND
RESULTS: In these studies, we evaluated quinidine concentration-QT relations during low-salt (10 mEq/day for 8 days) and high-salt (400 mEq/day for 8 days) diets, with or without beta blockade in normal volunteers. In the absence of beta blockade, the concentration producing a fixed (15%) increase in QTc was significantly lower with salt restriction: 1.2 +/- 0.4 microg/mL (low salt) versus 2.2 +/- 0.4 microg/mL (high salt) (P < 0.01). With beta blockade, this difference was abolished: 1.9 +/- 0.3 microg/mL (low salt + beta blockade) versus 2.1 +/- 0.3 microg/mL (high salt + beta blockade). QT morphologic abnormalities including bifid T waves and U waves were abolished with beta-adrenergic blockade.
CONCLUSION: Sympathetic activation by a low-salt diet not only modulates drug disposition but also increases sensitivity to drug-induced QT prolongation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11204091     DOI: 10.1046/j.1540-8167.2001.00009.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  4 in total

1.  Lasting reduction of heart transplant tachycardia with ivabradine is effective and well tolerated: results of 48-month study.

Authors:  Ruoyu Zhang; Dmitry Bobylev; Penelope Stiefel; Axel Haverich; Christoph Bara
Journal:  Clin Res Cardiol       Date:  2012-03-04       Impact factor: 5.460

Review 2.  Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes: an overview.

Authors:  Fabrizio De Ponti; Elisabetta Poluzzi; Andrea Cavalli; Maurizio Recanatini; Nicola Montanaro
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

3.  Factors affecting the degree of QT prolongation with drug challenge in a large cohort of normal volunteers.

Authors:  Prince J Kannankeril; Kris J Norris; Shannon Carter; Dan M Roden
Journal:  Heart Rhythm       Date:  2011-03-21       Impact factor: 6.343

4.  Comparison of electrocardiographic parameters in dogs with different stages of myxomatous mitral valve disease.

Authors:  Yejin Na; Dohee Lee; Taesik Yun; Yoonhoi Koo; Yeon Chae; Hakhyun Kim; Mhan-Pyo Yang; Byeong-Teck Kang
Journal:  Can J Vet Res       Date:  2021-10       Impact factor: 1.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.